Fyffes was among the best performers in Dublin yesterday as investors gained in confidence that it may get its $1 billion proposed merger with Chiquita away, following a scheduled shareholders’ meeting next month. Photograph: Simon Dawson/Bloomberg

European shares eked out small gains in thin trading across the continent yesterday, but most European bourses closed off their morning highs, after (...)

Tim Hortons employees prepare coffee before the company’s annual general meeting in Toronto. Burger King Worldwide is in talks to acquire Tim Hortons. The combined company would be headquartered in Canada, where Tim Hortons is based and taxes are generally lower than in the US. Photograph: Peter Jones/Reuters
Inversion express slow to crawl

President Barack Obama’s full- throated denunciation of overseas mergers that lower US companies’ taxes is throwing cold water on potential deals. On (...)

Steven Cohen: a judge ruled yesterday that the entire case against him and SAC can go forward. Photograph: Scott Eells/Bloomberg

A US federal judge has rejected billionaire investor Steven A Cohen’s bid to dismiss lawsuits by shareholders of pharma firms Elan and Wyeth who clai(...)

Aer Lingus closed down 1.6 per cent at €1.314 after it emerged that Denis O’Brien had sold 4.1 million shares in the airline, to reduce his stake to 2.4 per cent. Photograph: Peter Muhly/Getty

European stocks dropped to their lowest level in more than three months as concern mounted about a build-up of Russian troops along the border with(...)

Walgreens  pharmacy chain announced a  deal to acquire full control of Switzerland-based Alliance Boots – but without an inversion that could have saved the company billions of dollars in taxes. Photograph: Reuters

Billions of dollars were wiped off the value of European healthcare companies yesterday after the Obama administration threatened action to halt the w(...)

 AstraZeneca raised its sales and earnings forecasts for the year on Thursday, showing resilience after seeing off a $118 billion takeover approach from rival Pfizer two months ago. Photo: Bloomberg

AstraZeneca raised its sales and earnings forecasts for the year on Thursday, showing resilience after seeing off a $118 billion takeover approach fr(...)

AstraZeneca has boosted its lung drugs business with a $2.1 billion Almirall deal. Photo: Bloomberg

AstraZeneca has taken a major step to build up its respiratory medicine business by striking a deal worth up to $2.1 billion for the rights to Spanish(...)

Dublin law firm Matheson  on Sir John Rogerson’s Quay. A series of European law firms are aggressively pitching low corporate taxes in their countries to prospective US clients.

A series of European law firms are aggressively pitching low corporate taxes in their countries to prospective US clients, seeking to tap into the tax(...)

Mammoth: AbbVie’s $53 billion acquisition of Dublin-headquartered Shire

AbbVie’s mammoth $53 billion acquisition of Dublin-headquartered Shire is, by any metric, the largest tax inversion deal in US financial history. By t(...)

A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange on Friday. Photograph: Reuters

AbbVie defended plans to shift its tax residence to the UK after agreeing to buy Shire for £32 billion and urged US politicians to consider comprehens(...)